Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ)
CNY 9.12
(-0.44%)
CNY 9.12
(-0.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -64.76 Million | -120.85 Million | 72.32 Million | 382.35 Million | 337.91 Million | 175.91 Million |
| Net Income | -223.25 Million | -164.17 Million | 39.53 Million | 322.17 Million | 306.88 Million | 192.36 Million |
| Depreciation & Amortization | 159.45 Million | 123.83 Million | 98.56 Million | 73.93 Million | 66.52 Million | 52.83 Million |
| Deferred income taxes | -4.7 Million | -723.43 Thousand | -18.16 Million | -3.79 Million | 1.71 Million | -1.6 Million |
| Stock-based compensation | 7.03 Million | 1.65 Million | 6.31 Million | - | 771.51 Thousand | 4.85 Million |
| Change in working capital | -122.98 Million | -301.97 Million | -233.3 Million | -73.49 Million | -98.96 Million | -109.37 Million |
| Other non-cash items | 39.02 Million | 221.46 Million | 167.51 Million | 59.73 Million | 63.46 Million | 40.09 Million |
| Investing Cash Flow | -354.5 Million | -508.33 Million | -735.48 Million | -548.5 Million | -351.45 Million | -161.43 Million |
| Investments in PPE | -242.22 Million | -459.41 Million | -679.59 Million | -449.23 Million | -324.9 Million | -163.88 Million |
| Acquisitions | 1.6 Million | 3.8 Million | 296.28 Thousand | 457.12 Million | 325.48 Million | -1.38 Million |
| Investment purchases | -161.7 Million | -302.8 Million | -520.85 Million | -208.25 Million | -130 Million | -306.35 Million |
| Sales/Maturities of investments | 47.81 Million | 250.06 Million | 448.47 Million | 101.09 Million | 102.86 Million | 310.18 Million |
| Other Investing Activities | -112.27 Million | 0.81 | 16.19 Million | -449.23 Million | -324.9 Million | 0.45 |
| Financing Cash Flow | 149.76 Million | 282.98 Million | 349.61 Million | 912.69 Million | 30.81 Million | 169.74 Million |
| Debt repayment | -206.04 Million | -830.48 Million | -488.5 Million | -596.5 Million | -716.99 Million | -421.33 Million |
| Dividends payments | -55.79 Million | -54.58 Million | -110 Million | -56.76 Million | -43.91 Million | -79.74 Million |
| Common Stock Repurchased | -20.53 Million | -72.94 Million | -105.11 Million | 1.15 Million | -96.91 Million | -3.1 Million |
| Common Stock Issuance | -377.35 Thousand | 72.94 Million | 105.11 Million | -1.15 Million | 96.91 Million | - |
| Other Financing Activities | -489.15 Thousand | 1.16 Billion | 977.29 Million | 1.59 Billion | 826.31 Million | 670.82 Million |
| Accounts receivables | -159.44 Million | -273.94 Million | -199.38 Million | -152.72 Million | -149.72 Million | -92.82 Million |
| Accounts payables | -33.38 Million | 232.27 Million | 139.09 Million | 135.39 Million | 77.86 Million | 8.03 Million |
| Inventory | 74.54 Million | -259.58 Million | -154.85 Million | -52.36 Million | -28.82 Million | -22.97 Million |
| Other working capital | 7.03 Million | -723.43 Thousand | -18.16 Million | -3.79 Million | 1.71 Million | -86.39 Million |
| Cash at beginning of period | 847.25 Million | 1.18 Billion | 1.49 Billion | 758.81 Million | 741.54 Million | 552.94 Million |
| Cash at end of period | 580.75 Million | 847.25 Million | 1.18 Billion | 1.49 Billion | 758.81 Million | 741.54 Million |
| Capital Expenditure | -242.22 Million | -459.41 Million | -679.59 Million | -449.23 Million | -324.9 Million | -163.88 Million |
| Effect of forex changes on cash | 3 Million | 9.5 Million | 737.31 Thousand | -8.6 Million | -5137.49 | 4.37 Million |
| Net cash flow / Change in cash | -266.49 Million | -336.68 Million | -312.81 Million | 737.93 Million | 17.27 Million | 188.6 Million |
| Free Cash Flow | -306.98 Million | -580.26 Million | -607.27 Million | -66.88 Million | 13 Million | 12.02 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -39.61 Million | -23.92 Million | 1.46 Million | -223.25 Million | -119.16 Million | -21.96 Million |
| Depreciation & Amortization | - | 42.83 Million | 42.83 Million | 159.45 Million | 159.45 Million | -78.26 Million |
| Deferred income taxes | - | - | - | -4.7 Million | - | 91.55 Million |
| Stock-based compensation | - | - | - | - | - | -2.48 Million |
| Change in working capital | - | 7.7 Million | - | -122.98 Million | -77.86 Million | -10.8 Million |
| Other non-cash items | 103.29 Million | 81.64 Million | 71.16 Million | 39.02 Million | -10.62 Million | 89.03 Million |
| Investing Cash Flow | -45.97 Million | -44.28 Million | -41.32 Million | -354.5 Million | -7.36 Million | -73.61 Million |
| Investments in PPE | -39.73 Million | -45.91 Million | -41.37 Million | -242.22 Million | -19.82 Million | -61.3 Million |
| Acquisitions | 21.68 Thousand | 832.1 Thousand | 3.5 Million | 1.6 Million | 768.48 Thousand | 774.3 Thousand |
| Investment purchases | -6.3 Million | - | - | -161.7 Million | - | -774.3 Thousand |
| Sales/Maturities of investments | 43.79 Thousand | 794.89 Thousand | 51.6 Thousand | 47.81 Million | -51.36 Thousand | -1.33 Million |
| Other Investing Activities | 21.68 Thousand | 1.62 Million | 54.71 Thousand | -112.27 Million | 12.46 Million | -10.97 Million |
| Financing Cash Flow | -16.96 Million | 61.27 Million | -57.57 Million | 149.76 Million | -5.63 Million | 46.29 Million |
| Debt repayment | -1.5 Million | -74.11 Million | -46.5 Million | -206.04 Million | -6.12 Million | -139 Million |
| Dividends payments | -16.16 Million | -12.4 Million | -14.28 Million | -55.79 Million | -11.26 Million | -16.6 Million |
| Common Stock Repurchased | - | - | - | -20.53 Million | -20.53 Million | - |
| Common Stock Issuance | - | - | - | -377.35 Thousand | -377.35 Thousand | - |
| Other Financing Activities | 707.54 Thousand | -425.94 Thousand | 3.21 Million | -489.15 Thousand | -489.15 Thousand | 201.89 Million |
| Accounts receivables | - | -13.55 Million | - | -159.44 Million | -159.44 Million | 60.76 Million |
| Accounts payables | - | - | - | -33.38 Million | - | - |
| Inventory | - | 21.25 Million | - | 74.54 Million | 74.54 Million | -68.7 Million |
| Other working capital | - | - | - | 7.03 Million | 7.03 Million | -2.86 Million |
| Cash at beginning of period | 589.39 Million | 555.98 Million | 580.75 Million | 847.25 Million | 641.39 Million | 600.18 Million |
| Cash at end of period | 589.83 Million | 589.39 Million | 555.98 Million | 580.75 Million | 580.75 Million | 641.39 Million |
| Capital Expenditure | -39.73 Million | -45.91 Million | -41.37 Million | -242.22 Million | -19.82 Million | -61.3 Million |
| Effect of forex changes on cash | -269.74 Thousand | 2.34 Million | 1.48 Million | 3 Million | 546.7 Thousand | 1.5 Million |
| Net cash flow / Change in cash | 438.05 Thousand | 33.41 Million | -24.77 Million | -266.49 Million | -60.64 Million | 41.2 Million |
| Free Cash Flow | 23.94 Million | -31.03 Million | 31.25 Million | -306.98 Million | -68.02 Million | 5.76 Million |
LFDJF
300956
AREIT
3737
TEP
PSMMY